Search
for
Sort by
Research 241–270 of 375
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- New insights into human hair: SAXS, SEM, TEM and EDX for Alopecia Areata investigations
- PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cultivation of Human Hair Follicle Cells
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Unravelling a novel role for cannabidivarin in the modulation of subventricular zone postnatal neurogenesis
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Combined drug triads for synergic neuroprotection in retinal degeneration
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Treatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Oral delivery of marine shellfish supramolecule peptides for skin wound healing
- Symptomatic hypercalcemia and scarring alopecia as presenting features of sarcoidosis
- Immune therapies for alopecia areata: evidence and new perspectives
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia
- Physicochemical properties of wild and cultivated Saccharina latissima macroalgae harvested in the Canadian boreal-subarctic transition zone
- Underactive bladder - an underestimated entity
- Biologics in the management of childhood atopic dermatitis
- Plants used in Traditional Treatment for Boils in Turkey
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Could red and near-infrared emitting fabric technology improve the severity of psoriasis, polymorphous light eruption, and alopecia areata?
- Teledermatology Service During the COVID-19 Pandemic in China: A Mobile Application-Based Retrospective Study
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Cytokine Engineering Approaches for Regenerative Medicine